SEB Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12B Buy
6,832,972
+1,096,324
+19% +$183M 4.14% 4
2026
Q2
$1.08B Sell
5,736,648
-217,769
-4% -$41M 4.06% 3
2026
Q1
$1.16B Buy
+5,954,417
New +$1.15B 4.95% 3

Other funds holding AZN

SEB Asset Management's AZN Position: Q3 2026 in Review

SEB Asset Management increased its AstraZeneca (AZN) stake by 19% in Q3 2026, buying an estimated $183M and bringing the position to 6,832,972 shares worth $1.12B. The position accounts for 4.14% of the portfolio, ranked #4.

SEB Asset Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16B in Q1 2026. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • SEB Asset Management held 6,832,972 shares of AstraZeneca worth $1.12B as of Q3 2026.
  • SEB Asset Management bought 1,096,324 AstraZeneca shares in Q3 2026, an estimated $183M.
  • AstraZeneca made up 4.14% of SEB Asset Management's portfolio in Q3 2026, its #4 holding.
  • SEB Asset Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's AstraZeneca position peaked at $1.16B in Q1 2026.
  • 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.